We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Xellia Found To Infringe Merck Anti-Fungal Med Patent

Law360, New York (July 1, 2015, 7:22 PM EDT) -- Xellia Pharmaceuticals ApS’ generic version of the anti-fungal medication Cancidas infringes on one of the patents held by Merck Sharp & Dohme Corp., a Delaware federal judge ruled on Tuesday....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.